Biomarin Pharmaceutical Inc (BMRN) — Capital Reinvestment Ratio
Biomarin Pharmaceutical Inc (BMRN) has a Capital Reinvestment Ratio of 0.41x as of December 2025, meaning it reinvests 0% of its operating cash flow ($99.64 Million) in capital expenditures ($40.72 Million). See BMRN net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biomarin Pharmaceutical Inc Capital Reinvestment Ratio (2009–2025)
This chart tracks Biomarin Pharmaceutical Inc's Capital Reinvestment Ratio across 12 annual periods. Check BMRN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year Capital Reinvestment Ratio for Biomarin Pharmaceutical Inc from 2009 to 2025. For live market cap and broader valuation context, see market value of Biomarin Pharmaceutical Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $827.99 Million | $103.04 Million | ▼ -26.8% |
| 2024 | 0.17x | $572.84 Million | $97.42 Million | ▼ -72.0% |
| 2023 | 0.61x | $159.26 Million | $96.69 Million | ▼ -11.7% |
| 2022 | 0.69x | $175.90 Million | $120.96 Million | ▲ +75.6% |
| 2021 | 0.39x | $304.54 Million | $119.22 Million | ▼ -75.7% |
| 2020 | 1.61x | $85.36 Million | $137.52 Million | ▼ -46.4% |
| 2019 | 3.00x | $48.26 Million | $145.03 Million | ▼ -58.0% |
| 2018 | 7.16x | $20.21 Million | $144.62 Million | ▲ +182.7% |
| 2012 | 2.53x | $17.61 Million | $44.57 Million | ▼ -69.2% |
| 2011 | 8.22x | $18.75 Million | $154.22 Million | ▲ +211.7% |
| 2010 | 2.64x | $18.75 Million | $49.46 Million | ▲ +157.8% |
| 2009 | 1.02x | $87.73 Million | $89.80 Million | — |